The ahmed versus baerveldt study: Three-year treatment outcomes

Ophthalmology

Volumn 120, Issue 11, 2013, Pages 2232-2240

  Christakis, Panos G ^a,b   Tsai, James C ^b   Kalenak, Jeffrey W ^c   Zurakowski, David ^d   Cantor, Louis B ^e   Kammer, Jeffrey A ^f   Ahmed, Iqbal I K ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Drs Massaro and Kalenak   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e INDIANA UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADULT; AGED; AHMED VALVE; ANTERIOR EYE CHAMBER DEPTH; ARTICLE; BAERVELDT GLAUCOMA IMPLANT; CHOROID DETACHMENT; CHOROID EFFUSION; CHOROID HEMORRHAGE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA EDEMA; DEVICE THERAPY; ENCAPSULATED BLEB; ENDOPHTHALMITIS; EPISCLERITIS; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; GLAUCOMA SURGERY; HIGH RISK PATIENT; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; IRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MEDICATION THERAPY MANAGEMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; SECONDARY GLAUCOMA; SURGICAL TECHNIQUE; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANTS; HUMANS; INTRAOCULAR PRESSURE; MALE; POSTOPERATIVE COMPLICATIONS; PROSTHESIS IMPLANTATION; RECURRENCE; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84887183646     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2013.04.018     Document Type: Article

References (36)

1. S.J. Gedde, J.C. Schiffman, W.J. Feuer Tube versus Trabeculectomy Study Group Treatment outcomes in the Tube Versus Trabeculectomy (TVT) Study after five years of follow-up Am J Ophthalmol 153 2012 789 803
2. Fluorouracil Filtering Surgery Study Group Five-year follow-up of the Fluorouracil Filtering Surgery Study Am J Ophthalmol 121 1996 349 366
3. S.J. Gedde, L.W. Herndon, J.D. Brandt Tube versus Trabeculectomy Study Group Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up Am J Ophthalmol 153 2012 804 814
4. J.W. Boyle IV, and P.A. Netland Incisional therapies: shunts and valved implants P.N. Schacknow, J.R. Samples, The Glaucoma Book: A Practical, Evidence-Based Approach to Patient Care 2010 Springer New York 813 830
5. D.S. Minckler, B.A. Francis, and E.A. Hodapp Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology Ophthalmology 115 2008 1089 1098
6. M.R. Wilson, U. Mendis, A. Paliwal, and V. Haynatzka Long-term follow-up of primary glaucoma surgery with Ahmed glaucoma valve implant versus trabeculectomy Am J Ophthalmol 136 2003 464 470
7. P.Y. Ramulu, K.J. Corcoran, S.L. Corcoran, and A.L. Robin Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004 Ophthalmology 114 2007 2265 2270
8. D.S. Minckler, S.S. Vedula, and T.J. Li Aqueous shunts for glaucoma Cochrane Database Syst Rev 2 2006 CD004918
9. Q.H. Nguyen Primary surgical management refractory glaucoma: tubes as initial surgery Curr Opin Ophthalmol 20 2009 122 125
10. M.C. Huang, P.A. Netland, and A.L. Coleman Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant Am J Ophthalmol 127 1999 27 33
11. K. Nouri-Mahdavi, and J. Caprioli Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve Am J Ophthalmol 136 2003 1001 1008
12. J.C. Tsai, C.C. Johnson, and M.S. Dietrich The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a single-surgeon comparison of outcome Ophthalmology 110 2003 1814 1821
13. J.C. Tsai, C.C. Johnson, J.A. Kammer, and M.S. Dietrich The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon Ophthalmology 113 2006 913 917
14. R.S. Ayyala, D. Zurakowski, and J.A. Smith A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma Ophthalmology 105 1998 1968 1976
15. R. Krishna, D.G. Godfrey, and D.L. Budenz Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants Ophthalmology 108 2001 621 626
16. M.T. Britt, L.D. LaBree, and M.A. Lloyd Randomized clinical trial of the 350-mm2 versus the 500-mm2 Baerveldt implant: longer term results: is bigger better? Ophthalmology 106 1999 2312 2318
17. R.J. Goulet III, A.D. Phan, L.B. Cantor, and D. WuDunn Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant Ophthalmology 115 2008 1141 1147
18. D.K. Heuer, M.A. Lloyd, and D.A. Abrams Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucomas in aphakia and pseudophakia Ophthalmology 99 1992 1512 1519
19. T. Pan, M.S. Stay, and V.H. Barocas Modeling and characterization of a valved glaucoma drainage device with implications for enhanced therapeutic efficacy IEEE Trans Biomed Eng 52 2005 948 951
20. H.M. Syed, S.K. Law, and S.H. Nam Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison J Glaucoma 13 2004 38 45
21. J.C. Wang, J.L. See, and P.T. Chew Experience with the use of Baerveldt and Ahmed glaucoma drainage implants in an Asian population Ophthalmology 111 2004 1383 1388
22. P.G. Christakis, J.C. Tsai, and D. Zurakowski The Ahmed Versus Baerveldt Study: design, baseline patient characteristics, and intraoperative complications Ophthalmology 118 2011 2172 2179
23. D.K. Heuer, K. Barton, and F. Grehn Consensus on definitions of success T.M. Shaarawy, M.B. Sherwood, F. Grehn, WGA Guidelines on Design and Reporting of Glaucoma Surgical Trials 2008 Kugler Amsterdam, The Netherlands 15 24 Available at www.worldglaucoma.org/Download/dl-files.php?id=1 Accessed April 2, 2013
24. P.G. Christakis, J.W. Kalenak, and D. Zurakowski The Ahmed Versus Baerveldt study: one-year treatment outcomes Ophthalmology 118 2011 2180 2189
25. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 2000 429 440
26. P.A. Netland, K. Ishida, and J.W. Boyle The Ahmed glaucoma valve in patients with and without neovascular glaucoma J Glaucoma 19 2010 581 586
27. P.A. Sidoti, T.R. Dunphy, and G. Baerveldt Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma Ophthalmology 102 1995 1107 1118
28. P. Tranos, G. Bhar, and B. Little Postoperative intraocular pressure spikes: the need to treat Eye (Lond) 18 2004 673 679
29. D.L. Budenz, K. Barton, W.J. Feuer Ahmed Baerveldt Comparison Study Group Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up Ophthalmology 118 2011 443 452
30. K.S. Schwartz, R.K. Lee, and S.J. Gedde Glaucoma drainage implants: a critical comparison of types Curr Opin Ophthalmol 17 2006 181 189
31. J.D. Stein, A.N. McCoy, and S. Asrani Surgical management of hypotony owing to overfiltration in eyes receiving glaucoma drainage devices J Glaucoma 18 2009 638 641
32. C.H. Hong, A. Arosemena, D. Zurakowski, and R.S. Ayyala Glaucoma drainage devices: a systematic literature review and current controversies Surv Ophthalmol 50 2005 48 60
33. A.C. Molteno, M. Fucik, A.G. Dempster, and T.H. Bevin Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation Ophthalmology 110 2003 2198 2206
34. L. Choritz, K. Koynov, and G. Renieri Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion Invest Ophthalmol Vis Sci 51 2010 4047 4053
35. A.A. Shah, D. WuDunn, and L.B. Cantor Shunt revision versus additional tube shunt implantation after failed tube shunt surgery in refractory glaucoma Am J Ophthalmol 129 2000 455 460
36. E.K. Lee, Y.J. Yun, and J.E. Lee Changes in corneal endothelial cells after Ahmed glaucoma valve implantation: 2-year follow-up Am J Ophthalmol 148 2009 361 367